Genomic Health Inc (GHDX) Gross Profit Margin starting from the third quarter 2019 to third quarter 2018, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Genomic Health Inc  (NASDAQ: GHDX)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Genomic Health Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GHDX Gross Profit Margin (Sep 30 2019)
Q3 		(Jun 30 2019)
Q2 		(Mar 31 2019)
Q1 		(Dec 31 2018)
Q4 		(Sep 30 2018)
Q3
Y / Y Revenue Change 12.93 %
Seq. Revenue Change 0.19 %
Revenue In Millions $114.36
Gross Profit Margin 83.64 %
Gross Profit Margin Total Ranking # 416
Gross Profit In Millions $95.65
Y / Y Gross Profit Change 11.55 %
Seq. Gross Profit Change -0.85 %


Commenting Third Quarter 2019 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 83.64 % due to increase in Cost of Sales and despite Revenue increase of 0.19 % to $114 millions.
Company's Gross Profit Margin in III. Quarter, was above company average.


Observing third quarter 2019 results within Medical Laboratories industry only one other company has achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 416, from total ranking in the previous quarter at 422.
Learn about Gross Margin
GHDX's Gross Profit Margin third quarter 2019 Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 79
Overall # 400

Gross Profit Margin Statistics
High Average Low
89.72 % 83.36 % 79.78 %
(Dec 31 2013)   (Mar 31 2018)


GHDX Gross Income Trends • More of GHDX's Profitabilty Ratios • GHDX Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
GHDX's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
GHDX's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for GHDX's Competitors
Gross Profit Margin Profit Margin for Genomic Health Inc's Suppliers
Gross Profit Margin Profit Margin for GHDX's Customers

You may also want to know
GHDX's Annual Growth Rates GHDX's Profitability Ratios GHDX's Asset Turnover Ratio GHDX's Dividend Growth
GHDX's Roe GHDX's Valuation Ratios GHDX's Financial Strength Ratios GHDX's Gross Profit Growth
GHDX's Roa GHDX's Inventory Turnover Ratio GHDX's Growth Rates GHDX's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2019, within Medical Laboratories Industry Gross Profit MarginSep 30 2019 MRQ Gross ProfitSep 30 2019 MRQ Revenue
Incyte Corporation  94.55 %$ 521.541  Millions$ 551.581  Millions
Castle Biosciences Inc   88.43 %$ 13.066  Millions$ 14.775  Millions
Genomic Health Inc  83.64 %$ 95.646  Millions$ 114.355  Millions
Exact Sciences Corporation  75.89 %$ 166.046  Millions$ 218.805  Millions
Veracyte Inc   70.57 %$ 21.859  Millions$ 30.973  Millions
Caredx Inc   66.01 %$ 22.317  Millions$ 33.811  Millions
Nrc Health  62.70 %$ 20.356  Millions$ 32.465  Millions
Fulgent Genetics Inc   62.45 %$ 6.462  Millions$ 10.347  Millions
Capforce Inc   59.52 %$ 0.386  Millions$ 0.648  Millions
Exagen Inc   54.18 %$ 5.656  Millions$ 10.439  Millions
Vyant Bio Inc   53.60 %$ 1.109  Millions$ 2.069  Millions
Luna Innovations Inc  50.41 %$ 9.285  Millions$ 18.421  Millions
Natera Inc   48.48 %$ 37.771  Millions$ 77.909  Millions
Advanced Container Technologies Inc   48.41 %$ 0.255  Millions$ 0.526  Millions
Charles River Laboratories International inc   47.32 %$ 316.057  Millions$ 667.951  Millions
Psychemedics Corporation  44.48 %$ 4.382  Millions$ 9.852  Millions
Invitae Corporation  43.16 %$ 24.391  Millions$ 56.511  Millions
Quest Diagnostics Inc  35.38 %$ 692.000  Millions$ 1,956.000  Millions
American Shared Hospital Services  34.20 %$ 1.813  Millions$ 5.301  Millions
Iqvia Holdings Inc   33.12 %$ 917.000  Millions$ 2,769.000  Millions
Personalis Inc   32.82 %$ 5.629  Millions$ 17.153  Millions
Inotiv Inc   32.54 %$ 4.812  Millions$ 14.786  Millions
Bionexus Gene Lab Corp   31.75 %$ 0.008  Millions$ 0.024  Millions
Medpace Holdings Inc   29.67 %$ 64.168  Millions$ 216.238  Millions
Hologic Inc  28.82 %$ 249.500  Millions$ 865.800  Millions
Labcorp Holdings Inc   27.91 %$ 817.300  Millions$ 2,928.500  Millions
Syneos Health Inc   22.37 %$ 263.354  Millions$ 1,177.028  Millions
Kushco Holdings Inc   20.06 %$ 9.421  Millions$ 46.972  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.